ZYDUSLIFENSEZydus Lifesciences LimitedMediumNeutral
Announced Wed, 25 Mar · 16:18 IST

Zydus Lifesciences Limited has informed the Exchange about General Updates

Regulatory & Legal View source PDF

ZYDUSLIFE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-2.6%1-day move
₹902.60
prior close
₹901.95
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.2+0.2+0.1+0.6-2.6-4.1-4.3-3.8-3.2-0.2+2.8+3.3+20.4+24.6
Up moveDown movePending
AI summary

Zydus Lifesciences has received an Order-in-Original from the Assistant Commissioner of State Tax, Gujarat, demanding Rs. 3.28 crore (including interest and penalty) under Section 74 of the CGST Act, 2017. The demand relates to the alleged inadmissible availment of Input Tax Credit for the financial year 2019-20. The company received the order on March 24, 2026, and has stated it intends to appeal, citing strong merits based on past High Court and Supreme Court judgments on similar matters. The company has confirmed there is no material financial impact from this order.

Likely market impact

The Rs. 3.28 crore demand is small relative to the company's size and the company is contesting it confidently, so the stock price impact is likely to be negligible. Investors should note the pending appeal and monitor for any adverse outcome, but the company's own assessment suggests no material risk.